Analysts highlight MariTide's upcoming updates and near-term catalysts, while Amgen's price targets shift amid steady outlook ...

The firm is expecting Phase III readouts this year for its FGFR2b drug bemarituzumab and is advancing a second KRAS inhibitor to the clinic.

Q1 2025 Earnings Call Transcript May 1, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $4.9, expectations were ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...

Amgen (NASDAQ:AMGN) reported a 24% rise in first-quarter profit, fueled by strong product sales, while reaffirming full-year ...

Amgen will invest $900M to expand its Columbus region biomanufacturing facility, bringing total investment in Central Ohio to ...

Amgen and Columbus State Community College are adding an advanced manufacturing certificate program, and Amgen is repeating ...

Amgen, based in Thousand Oaks, California, first broke ground in New Albany in 2021. Here's how the company plans to expand.

Biotechnology company Amgen announced a $900 million manufacturing expansion in Ohio on Friday, bringing 350 new jobs to ...

Thousand Oaks-based Amgen is continuing its commitment to its latest facilities here in the United States after the biotech company announced a $900 million expansion of its Ohio manufacturing ...

Amgen has announced a significant expansion of the Ohio manufacturing facility in the US, with an investment of $900m.

Amgen (NasdaqGS:AMGN) recently announced a significant $900 million expansion in its Ohio manufacturing facility, aiming to ...